Aceruloplasminemia
What is Aceruloplasminemia?
Aceruloplasminemia is a rare genetic disorder that affects how your body handles iron. People with this condition lack a protein called ceruloplasmin, which normally helps move iron out of tissues and into the bloodstream. Without ceruloplasmin, iron gets trapped and builds up in organs like the brain, liver, and pancreas.
This iron buildup creates a unique pattern in blood tests. Ferritin, a protein that stores iron, becomes very high because tissues are overloaded with iron. At the same time, transferrin saturation stays low because iron cannot move properly from tissues into the blood. This paradox helps doctors identify the condition.
The disorder is inherited in an autosomal recessive pattern. This means you need to receive a faulty gene from both parents to develop the condition. Symptoms typically appear in adulthood, usually between ages 40 and 60.
Symptoms
- Progressive memory loss and cognitive decline
- Involuntary movements or tremors
- Difficulty with coordination and balance
- Diabetes, often appearing in middle age
- Changes in skin color or pigmentation
- Vision problems, especially retinal degeneration
- Fatigue and weakness
- Anemia despite high iron stores
Many people have no symptoms in early stages. Iron accumulation happens slowly over years, so brain and organ damage develops gradually before becoming noticeable.
Concerned about Aceruloplasminemia? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Aceruloplasminemia is caused by mutations in the CP gene, which provides instructions for making ceruloplasmin. This protein has two critical jobs. It helps oxidize iron so it can bind to transferrin and travel through the bloodstream. It also acts as an antioxidant to protect tissues from iron-related damage. When ceruloplasmin is absent, iron cannot exit cells properly and accumulates in organs.
The condition is extremely rare, with only a few hundred cases reported worldwide. Most cases have been identified in Japan, though it occurs in all ethnic groups. Because both parents must carry the gene mutation, the condition often appears in families with consanguinity, meaning parents who are blood relatives. There are no lifestyle or environmental risk factors, only genetic inheritance.
How it's diagnosed
Diagnosis starts with blood tests that reveal a characteristic pattern. Ferritin levels are markedly elevated, often 10 to 20 times higher than normal. Transferrin saturation is low, typically below 20 percent. This combination of high ferritin with low transferrin saturation is unusual and suggests a problem with iron mobilization. Rite Aid testing can measure both ferritin and transferrin saturation to help identify this pattern.
If blood tests suggest aceruloplasminemia, doctors will measure ceruloplasmin levels directly. People with this condition have absent or extremely low ceruloplasmin. Additional tests include MRI scans to detect iron deposits in the brain and liver, eye exams to check for retinal damage, and genetic testing to confirm CP gene mutations. Early detection through blood testing helps prevent severe organ damage.
Treatment options
- Iron chelation therapy with medications like deferasirox or deferoxamine to remove excess iron from tissues
- Regular monitoring of ferritin levels and organ function
- Blood sugar management for diabetes, often with insulin or oral medications
- Antioxidant supplements may help protect against iron-related oxidative damage
- Limiting dietary iron intake by reducing red meat and avoiding iron supplements
- Avoiding vitamin C supplements, which increase iron absorption
- Regular neurological evaluations to monitor brain function
- Eye exams to detect and manage retinal problems
- Physical therapy for movement disorders when needed
Concerned about Aceruloplasminemia? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
The first symptoms usually appear between ages 40 and 60. Diabetes is often the earliest sign, followed by neurological symptoms like tremors or difficulty walking. Some people notice vision changes or cognitive problems first. Symptoms develop slowly as iron accumulates over many years.
Aceruloplasminemia causes iron to build up inside tissues while blood iron remains low. This is opposite to hemochromatosis, where both tissue and blood iron are high. The pattern of high ferritin with low transferrin saturation is unique to ceruloplasmin deficiency. This paradox helps doctors distinguish it from other iron overload conditions.
Yes, blood tests show a characteristic pattern. Ferritin is very high, often 10 to 20 times normal levels. Transferrin saturation is low, usually below 20 percent. These findings together suggest the condition and prompt doctors to measure ceruloplasmin levels directly.
Yes, it is inherited in an autosomal recessive pattern. You must receive a mutated CP gene from both parents to develop the condition. If you inherit only one mutated gene, you are a carrier without symptoms. Genetic counseling helps families understand their risk.
Aceruloplasminemia is extremely rare, with only a few hundred cases reported worldwide. Most documented cases are from Japan, though the condition affects all ethnic groups. The exact prevalence is unknown due to underdiagnosis.
Iron accumulates primarily in the brain, liver, and pancreas. Brain iron deposits cause movement disorders and cognitive decline. Liver iron can lead to mild liver disease. Pancreatic iron damages insulin-producing cells, causing diabetes. The retina also accumulates iron, leading to vision problems.
There is no cure, but treatment can slow progression and manage symptoms. Iron chelation therapy removes excess iron from tissues. Diabetes requires blood sugar management with medications. Early detection and treatment help prevent severe organ damage and preserve quality of life.
Ferritin stores iron inside cells. Without ceruloplasmin, iron cannot exit cells and accumulate in the bloodstream. Tissues become overloaded with trapped iron, causing ferritin to rise dramatically. This reflects the total body iron burden despite low blood iron levels.
Yes, limiting dietary iron can help reduce further accumulation. Reduce red meat, liver, and fortified cereals. Avoid iron supplements completely. Also avoid vitamin C supplements, which enhance iron absorption from food. Work with a nutritionist to maintain a balanced diet while limiting iron intake.
Regular monitoring is essential. Ferritin levels should be checked every 3 to 6 months to track treatment response. Annual MRI scans help monitor iron in the brain and liver. Eye exams and neurological evaluations should happen yearly. Your doctor will adjust testing frequency based on your condition and treatment.